|
|
Created by Mark George
about 13 years ago
|
|
| Question | Answer |
| Name a biguanide. | Metformin |
| 3 main actions of biguanides | Inhibits hepatic glucose production. Increases peripheral uptake of glucose Increases insulin sensitivity |
| Most serious SE of metformin | lactic acidosis |
| Most COMMON SEs of metformin | GI disturbances (nausea, vomiting, diarrhea, flatulence etc...). B12 depletion. |
| MOA of sulphonylureas | Closes K+ channels causing insulin release |
| Do sulphonylureas cause hypoglycemia? | YES |
| MOA of thiazolidinediones | Binds to PPAR-y receptors which regulates CHO & lipid metabolism. Increases insulin sensitivity in adipose tissue. |
| What is a requirement for use of hypoglycemic agents? | A pancreas that is capable of secreting insulin. |
| Name a Sulphonylurea. | Glibenclamide |
| Name a thiazolidinedione. | Pioglitazone |
| Effects of sulphonylureas | Stimulates B-cell Insulin secretion. Increases insulin receptors on target cells. Inhibits gluconeogenesis |
| Effects of Biguanides | Inhibition of hepatic glucose production. Increase Insulin Snsitivty Increase periph uptake of glucose. |
| Can biguanides cause hypoglycemia? | NO |
| 2 elements of DKA | Deficiency of insulin & increased counter-regulatory hormones |
| Acute complications of DM | Hypoglycemia. Diabetic Ketoacidosis. |
| Chronic complications of DM | Microvascular and macrovascular disease. Neuropathies. Infections. Chronic hyperglycemia. |
| Macrovascular diseases? | CAD. CVD. |
| Microvascular diseases? | Retinopathy. Nephropathy. |
Want to create your own Flashcards for free with GoConqr? Learn more.